Ascendis Pharma Ownership | Who Owns Ascendis Pharma?
Ascendis Pharma Ownership Summary
Ascendis Pharma is owned by 29.15% institutional investors, 0.78% insiders, and 70.07% retail investors. Ra capital management is the largest institutional shareholder, holding 17.13% of ASND shares. MFS Mid Cap Growth Equity is the top mutual fund, with 2.17% of its assets in Ascendis Pharma shares.
ASND Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Ascendis Pharma | 29.15% | 0.78% | 70.07% |
| Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 10.28M | 17.13% | $1.60B |
| Westfield capital management co lp | 5.53M | 9.64% | $761.07M |
| Avoro capital advisors | 5.22M | 8.69% | $813.28M |
| Fmr | 4.73M | 8.25% | $650.99M |
| Artisan partners limited partnership | 4.45M | 7.76% | $612.69M |
| Janus henderson group | 4.38M | 7.64% | $602.91M |
| Capital investors | 2.86M | 4.99% | $394.18M |
| T. rowe price investment management | 2.73M | 4.75% | $375.23M |
| Price t rowe associates inc /md/ | 2.28M | 3.98% | $314.33M |
| Massachusetts financial services co /ma/ | 1.87M | 3.26% | $257.11M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ra capital management | 10.28M | 26.76% | $1.60B |
| Q global advisors | 219.46K | 25.98% | $32.77M |
| Resolute capital asset partners | 167.50K | 14.69% | $26.11M |
| Avoro capital advisors | 5.22M | 12.69% | $813.28M |
| Saturn v capital management | 198.98K | 10.73% | $27.39M |
| Acuta capital partners | 23.34K | 4.22% | $3.64M |
| Evolutionary tree capital management | 30.11K | 4.22% | $4.15M |
| Great point partners | 50.00K | 4.13% | $7.79M |
| Ghost tree capital | 86.72K | 3.70% | $11.83M |
| First turn management | 113.28K | 3.56% | $17.66M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| T. rowe price investment management | 2.73M | 0.23% | 960.50K |
| Capital investors | 2.86M | 0.07% | 753.86K |
| Westfield capital management co lp | 5.53M | 3.31% | 394.47K |
| Ubs group | 225.69K | 0.01% | 213.26K |
| Janus henderson group | 4.38M | 0.31% | 193.69K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Sofinnova investments | - | - | -734.28K |
| Paradigm biocapital advisors lp | - | - | -664.31K |
| Spyglass capital management | - | - | -652.84K |
| Wellington management group llp | 704.17K | 0.02% | -557.30K |
| Timessquare capital management | - | - | -500.92K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Braidwell lp | 106.71K | 0.58% | 106.71K | $16.63M |
| Artal group | 101.10K | 0.35% | 101.10K | $13.79M |
| Integral health asset management | 100.00K | 1.66% | 100.00K | $15.59M |
| Great point partners | 50.00K | 4.13% | 50.00K | $7.79M |
| Capital sarl | 23.81K | 0.08% | 23.81K | $3.28M |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -1.00 |
| Allworth financial lp | -2.00 |
| Thurston, springer, miller, herd & titak | -14.00 |
| Eagle bay advisors | -23.00 |
| Hoey investments | -24.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 32 | -85.71% | 17,493,613 | -72.74% | 29 | 0.23% | 16 | -87.20% | 9 | -85.94% |
| Dec 31, 2024 | 221 | -5.96% | 64,027,760 | 1.63% | 111 | 0.93% | 123 | 0.82% | 64 | -7.25% |
| Sep 30, 2024 | 233 | 9.39% | 62,931,094 | 3.91% | 109 | 0.97% | 121 | 10.00% | 68 | - |
| Jun 30, 2024 | 213 | 4.93% | 60,561,767 | -0.18% | 106 | 0.94% | 109 | -1.80% | 68 | 36.00% |
| Mar 31, 2024 | 203 | 1.50% | 60,669,584 | 0.76% | 106 | 0.94% | 111 | 11.00% | 50 | -23.08% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| MFS Mid Cap Growth Equity | 1.30M | 2.17% | -14.22K |
| MFS Mid Cap Growth A | 1.30M | 2.16% | - |
| American Funds Growth Fund of Amer A | 1.06M | 1.77% | -1.77K |
| Capital Group Growth Fnd of Amer Comp | 1.06M | 1.76% | -1.77K |
| T. Rowe Price US Mid-Cap Growth Equity | 1.02M | 1.70% | -1.60K |
| T. Rowe Price Mid-Cap Growth | 1.02M | 1.70% | -1.20K |
| Janus Henderson Enterprise D | 976.88K | 1.62% | - |
| Janus Inst Mid Cap Growth CF | 976.88K | 1.61% | - |
| T. Rowe Price Health Sciences | 948.31K | 1.58% | 69.89K |
| Artisan Mid Cap Investor | 938.85K | 1.56% | -29.92K |
ASND Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools